• EZ Cap™ Cas9 mRNA for Gene Editing

  2026-08-28

  EZ Cap™ Cas9 mRNA (5-moUTP) is capped, polyadenylated, in vitro transcribed Cas9 mRNA for guide-directed genome editing. Its defined RNA format supports transient experimental perturbation, while the cited Fyn–Stat3 zebrafish study provides a mechanistic framework for functional gene studies rather than a direct product-performance benchmark.

• Chloroquine Research Workflows and Applications

  2026-08-27

  Chloroquine BA1002 supports controlled studies of lysosomal pH, autophagic flux, TLR signaling, oncology phenotypes, malaria biology, and host-pathogen interactions. This guide converts its broad mechanism into practical dose-finding, pharmacogenomic, and troubleshooting workflows while separating research observations from clinical conclusions.

• P2RX1–CaMKII Apoptosis in Ph+ ALL

  2026-08-27

  Li et al. identify a P2RX1–calcium/CaMKII axis that suppresses PI3K/Akt signaling and promotes mitochondrial apoptosis in Philadelphia chromosome-positive acute lymphoblastic leukemia. The findings connect purinergic signaling with tyrosine kinase inhibitor sensitivity while highlighting the need for orthogonal cell-death assays in mechanistic validation.

• Decitabine: Assay Design & Reliability

  2026-08-26

  A scenario-based guide to using Decitabine (5-Aza-2'-deoxycytidine), SKU A1906, in viability, proliferation, and cytotoxicity workflows. It explains dose selection, solvent controls, interpretation of epigenetic versus cytotoxic effects, and practical criteria for choosing a reliable research reagent.

• S Tag Peptide (A6007): Practical Workflow

  2026-08-26

  S Tag Peptide (SKU A6007) is a 15-amino-acid RNase A-derived fusion tag used to support recombinant protein detection, antibody-based purification, and conditional protein solubility improvement. This guide covers construct design, solution handling, QC, and troubleshooting while defining limits for standalone RNase activity, ethanol-based workflows, and long-term aqueous storage.

• Amphotericin B Workflow for Fungal Research

  2026-08-25

  Build more reproducible fungal membrane, immune-signaling, and cell-viability assays with a concentration-aware Amphotericin B workflow. The approach also adapts assay logic from a canine epithelial toxicity study without confusing cytotoxicity controls with evidence of antifungal efficacy.

• Ambroxol Targets Nav1.8, TRPV1, and TRPA1

  2026-08-25

  This 2025 study defines a mechanistic basis for topical ambroxol analgesia by comparing its actions on human and rat Nav1.8 sodium channels and on the irritant receptors TRPV1 and TRPA1. The results identify marked species dependence, state-dependent sodium-channel inhibition, and direct modulation of TRPV1 and TRPA1, while also showing why in vitro findings should not be treated as proof of clinical efficacy.

• Sodium Dicloxacillin Monohydrate: From MIC to Model

  2026-08-24

  A translational framework for using sodium dicloxacillin monohydrate in MSSA research, connecting penicillin-binding protein inhibition with intracellular activity, free-drug exposure, pH effects, and model selection.

• From Microbial Control to Lineage Fidelity

  2026-08-23

  Translational stem cell workflows must separate contamination control from mechanisms of lineage commitment. This thought-leadership article connects Ethacridine lactate monohydrate research use with the YAP–TEAD super-enhancer biology reported in surface ectoderm differentiation, offering a disciplined framework for assay design, validation, and regenerative medicine development.

• MG-132: Proteostasis as an Experimental Signal

  2026-08-22

  MG-132 and Z-LLL-al provide a powerful way to connect proteasome inhibition with protein accumulation, oxidative stress, apoptosis, and cell-cycle remodeling. This guide adds a distinct perspective by using proteostasis as an assay-design variable and interpreting it alongside targeted protein degradation research.

• Precision Caspase Inhibition in Translational Research

  2026-08-21

  A mechanistic and strategic guide to using Caspase-3/7 Inhibitor I as a causal perturbation tool in apoptosis research, with insights from Candida krusei-induced bovine mammary epithelial cell death.

• YTHDF3–CENPI Signaling in Triple-Negative Breast Cancer

  2026-08-21

  A 2025 Frontiers in Oncology study identifies the m6A reader YTHDF3 as a TNBC-associated risk factor and links it mechanistically to stabilization and enhanced translation of CENPI mRNA. The findings connect epitranscriptomic RNA regulation with chromosome-segregation biology and provide a rationale for testing the YTHDF3–CENPI axis as a prognostic and therapeutic target.

• Liproxstatin-1 HCl: Ferroptosis Assay Strategy

  2026-08-20

  Liproxstatin-1 HCl is a nanomolar ferroptosis inhibitor for dissecting lipid peroxidation, GPX4 dependence, and organ-injury mechanisms. This guide focuses on assay interpretation, rescue controls, formulation, and translational limitations rather than repeating a standard pathway overview.

• Tigecycline in the Plasmid-Resistance Era

  2026-08-20

  Tigecycline offers translational researchers a mechanistically distinct way to study multidrug-resistant bacteria as carbapenemase genes move through hospital networks. This article connects the glycylcycline antibiotic’s 30S ribosomal activity with plasmid surveillance, CREC validation workflows, MRSA research, and infection-model design while clearly separating evidence from testable hypotheses.

• Naftifine HCl in Mechanism-First Assays

  2026-08-19

  Naftifine HCl is an allylamine antifungal agent that enables mechanism-first studies of fungal sterol disruption. This article connects squalene 2,3-epoxidase biology with the orthogonal assay logic of a landmark WNT/GSK3/β-catenin study, helping researchers design more interpretable antifungal experiments.

444 records 6/30 page Previous Next First page 上5页 678910 下5页 Last page